1101 - Antiviral Prescription in Children with Influenza in Emergency Departments (ED): New Vaccine Surveillance Network (NVSN), 2016–2020

Friday, October 13, 2023

11:00 AM – 11:15 AM US ET

Location: 252 AB

Presenting Author(s)

Tess Stopczynski, MS (she/her/hers)

Biostatistician
Vanderbilt University Medical Center
Nashville, TN, United States

Slides

Co-Author(s)

Justin Z. Amarin, MD (he/him/his)

Postdoctoral Research Fellow
Vanderbilt University Medical Center
Nashville, TN, United States
JA

James W. Antoon, MD, PhD, MPH

Vanderbilt University Medical Center
Nashville, Tennessee, United States
Olla Hamdan, B.Pharm (she/her/hers)

Student
Vanderbilt University Medical Center
Nashville, Tennessee, United States
LS

Laura S. Stewart, PhD

Program Manager
Vanderbilt University Medical Center
Nashville, Tennessee, United States
JC

James Chappell, MD, PhD

Vanderbilt University Medical Center
Nashville, Tennessee, United States
AS

Andrew J. Spieker, PhD

Assistant Professor
Vanderbilt University Medical Center
Nashville, Tennessee, United States
EK

Eileen J. Klein, MD, MPH

Professor
University of Washington School of Medicine
Seattle, Washington, United States
Janet A. Englund, MD

Professor
Seattle Children’s Hospital
Seattle, Washington, United States
Geoffrey A. Weinberg, MD (he/him/his)

Professor
University of Rochester School of Medicine & Dentistry
Rochester, NY, United States
PS

Peter G. Szilagyi, MD MPH

Professor
UCLA School of Medicine
Agoura Hills, California, United States
RH

Robert Hickey, MD

Professor
Childrens Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Marian G. Michaels, MD, MPH

Professor
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Flor M. Munoz, MD, MSc

Associate Professor of Pediatrics
Baylor College of Medicine
Houston, TX, United States
JB

Julie A. Boom, MD

Professor
Texas Children’s Hospital
Houston, Texas, United States
MS

Mary A. Staat, MD, MPH

Professor
Cincinnati Children’s Hospital Medical Center
Cincinnati, Ohio, United States
Elizabeth P. Schlaudecker, MD, MPH

Associate Professor of Pediatrics, Division of Infectious Diseases
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
JS

Jennifer E. Schuster, MD, MSc

Associate Professor
Children’s Mercy Kansas City
Kansas City, Missouri, United States
RS

Rangaraj Selvarangan, BVSc, PhD, D(ABMM), FIDSA, FAAM

Director
Children’s Mercy Kansas City
Kansas City, Missouri, United States
Angela P. Campbell, MD, MPH, FPIDS, FIDSA

Medical Officer
Centers for Disease Control and Prevention
Atlanta, GA, United States
HM

Heidi L. Moline, MD, MPH

Medical Officer
Centers for Disease Control and Prevention
Atlanta, Georgia, United States
VB

Veronica Burkel, MPH

Eagle Health Analytics / CDC
Atlanta, Georgia, United States
SO

Samantha M. Olson, MPH

Epidemiologist
Centers for Disease Control and Prevention
Atlanta, Georgia, United States
Natasha B. Halasa, MD, MPH (she/her/hers)

Craig Weaver Professor of Pediatrics
Vanderbilt University Medical Center
Nashville, TN, United States

Disclosure(s):

Flor M. Munoz, MD, MSc: CDC respiratory virus surveillance: Grant/Research Support (); Gilead: Grant/Research Support (); Moderna, sanofi, aztra zeneca, Merck, GSK: Advisor/Consultant (); NIH: DSMB (); NIH COVID-19 vaccines in pregnancy: Grant/Research Support (); Pfizer Pediatric COVID-19 vaccines: Grant/Research Support (); Pfizer, Dynavax, Monderna, Meissa, NIH: DSMB ()

Angela P. Campbell, MD, MPH, FPIDS, FIDSA: No financial relationships to disclose

Natasha B. Halasa, MD, MPH: Merck and Company, Inc.: Grant/Research Support (Ongoing)